Authors: SCHOLL SM BARON C SALAMARO J BEUZEBOC P DENEUX L BEUVON F POUILLART P

Citation: Sm. Scholl et al., THE IMMUNE-RESPONSE TO BREAST-CANCER, European journal of cancer, 34, 1998, pp. 149-149

Authors: THIOUNN N PAGES F FLAM T TARTOUR E MOSSERI V ZERBIB M BEUZEBOC P DENEUX L FRIDMAN WH DEBRE B

Citation: N. Thiounn et al., IL-6 IS A SURVIVAL PROGNOSTIC FACTOR IN RENAL-CELL CARCINOMA, Immunology letters, 58(2), 1997, pp. 121-124

Authors: TARTOUR E DENEUX L MOSSERI V JAULERRY C BRUNIN F POINT D VALIDIRE P DUBRAY B FRIDMAN WH RODRIGUEZ J

Citation: E. Tartour et al., SOLUBLE INTERLEUKIN-2 RECEPTOR SERUM LEVEL AS A PREDICTOR OF LOCOREGIONAL CONTROL AND SURVIVAL FOR PATIENTS WITH HEAD AND NECK-CARCINOMA - RESULTS OF A MULTIVARIATE PROSPECTIVE-STUDY, Cancer, 79(7), 1997, pp. 1401-1408

Authors: TARTOUR E BLAY JY DORVAL T ESCUDIER B MOSSERI V DOUILLARD JY DENEUX L GORIN I NEGRIER S MATHIOT C POUILLART P FRIDMAN WH

Citation: E. Tartour et al., PREDICTORS OF CLINICAL-RESPONSE TO INTERLEUKIN-2-BASED IMMUNOTHERAPY IN MELANOMA PATIENTS - A FRENCH MULTIINSTITUTIONAL STUDY, Journal of clinical oncology, 14(5), 1996, pp. 1697-1703

Authors: TARTOUR E DORVAL T MOSSERI V DENEUX L MATHIOT C BRAILLY H MONTERO F JOYEUX I POUILLART P FRIDMAN WH

Citation: E. Tartour et al., SERUM INTERLEUKIN-6 AND C-REACTIVE PROTEIN-LEVELS CORRELATE WITH RESISTANCE TO IL-2 THERAPY AND POOR SURVIVAL IN MELANOMA PATIENTS, British Journal of Cancer, 69(5), 1994, pp. 911-913